StayHappi Risperidone+Trihexyphenidyl 2mg/2mg Tablet
By StayHappi
Rx
10 Tablet in a Strip

Composition
Risperidone(2mg) + Trihexyphenidyl(2mg)

Manufacturer - Sarvagunaushdhi Pvt Ltd
13Th Floor, Pearl Best Hight-1, Netaji Subhash Place, Pitampura, Delhi North Delhi DL 110034 IN

Expires on or after
September, 2025

liver
When using StayHappi Risperidone+Trihexyphenidyl 2mg/2mg Tablet, it is important to exercise caution if you have liver disease. In such cases, dosage adjustment of the tablet may be necessary for your safety and well-being. It is highly advised to seek advice from your doctor regarding the appropriate usage of StayHappi Risperidone+Trihexyphenidyl 2mg/2mg Tablet to ensure it is suitable for individuals with liver conditions.

kidney
StayHappi Risperidone+Trihexyphenidyl 2mg/2mg Tablet should be used with caution in patients with kidney disease. Dose adjustment may be necessary. Kindly consult your doctor.

alcohol
Consuming alcohol with StayHappi Risperidone+Trihexyphenidyl 2mg/2mg Tablet can lead to increased drowsiness. It is important to be cautious about alcohol intake when taking this medication.

driving
Caution should be taken when driving while using StayHappi Risperidone+Trihexyphenidyl 2mg/2mg Tablet as it may cause blurring of vision, dizziness, mild nausea, and mental confusion, impacting driving ability.

pregnancy
StayHappi Risperidone+Trihexyphenidyl 2mg/2mg Tablet is considered potentially unsafe during pregnancy. While human studies are limited, animal studies suggest possible harm to the developing baby. It's essential to consult with your doctor to assess the benefits and risks before using this medication.

breastfeeding
StayHappi Risperidone+Trihexyphenidyl 2mg/2mg Tablet could be harmful during breastfeeding, as limited data indicates it may pass into breastmilk and harm the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | NEURO CNS |
Action Class | - |
₹29
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024